Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response

Clinical trial NCT01827930 · TERMINATED

Trial details

NCT number: NCT01827930
Sponsor: Institut Bergonié
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic-Phase

Start date: 2009-07-01
Primary completion: 2017-01-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.